Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Association of the hERG mutation with long-QT syndrome type 2, syncope and epilepsy.

Li G, Shi R, Wu J, Han W, Zhang A, Cheng G, Xue X, Sun C.

Mol Med Rep. 2016 Mar;13(3):2467-75. doi: 10.3892/mmr.2016.4859. Epub 2016 Feb 4.

2.

Genetics of inherited primary arrhythmia disorders.

Spears DA, Gollob MH.

Appl Clin Genet. 2015 Sep 18;8:215-33. doi: 10.2147/TACG.S55762. eCollection 2015. Review.

3.

Sports Participation in Genotype Positive Children With Long QT Syndrome.

Aziz PF, Sweeten T, Vogel RL, Bonney WJ, Henderson J, Patel AR, Shah MJ.

JACC Clin Electrophysiol. 2015 Mar-Apr;1(1-2):62-70.

4.

Behavioral influences on cardiac arrhythmias.

Lampert R.

Trends Cardiovasc Med. 2016 Jan;26(1):68-77. doi: 10.1016/j.tcm.2015.04.008. Epub 2015 Apr 17. Review.

PMID:
25983071
5.

Congenital and drug-induced long-QT syndrome: an update.

Wehrens XH, Doevendans PA.

Neth Heart J. 2004 Apr;12(4):165-172.

6.

Inherited arrhythmia syndromes leading to sudden cardiac death in the young: a global update and an Indian perspective.

Chockalingam P, Wilde AA.

Indian Heart J. 2014 Jan-Feb;66 Suppl 1:S49-57. doi: 10.1016/j.ihj.2013.11.008. Epub 2013 Dec 17. Review.

7.

Single nucleotide deletion mutation of KCNH2 gene is responsible for LQT syndrome in a 3-generation Korean family.

Park JK, Oh YS, Choi JH, Yoon SK.

J Korean Med Sci. 2013 Sep;28(9):1388-93. doi: 10.3346/jkms.2013.28.9.1388. Epub 2013 Aug 28.

8.

Differential conditions for early after-depolarizations and triggered activity in cardiomyocytes derived from transgenic LQT1 and LQT2 rabbits.

Liu GX, Choi BR, Ziv O, Li W, de Lange E, Qu Z, Koren G.

J Physiol. 2012 Mar 1;590(5):1171-80. doi: 10.1113/jphysiol.2011.218164. Epub 2011 Dec 19.

9.

Inherited cardiac arrhythmias: diagnosis, treatment, and prevention.

Beckmann BM, Pfeufer A, Kääb S.

Dtsch Arztebl Int. 2011 Sep;108(37):623-33; quiz 634. doi: 10.3238/arztebl.2011.0623. Epub 2011 Sep 16. Review.

10.

Unexplained drownings and the cardiac channelopathies: a molecular autopsy series.

Tester DJ, Medeiros-Domingo A, Will ML, Ackerman MJ.

Mayo Clin Proc. 2011 Oct;86(10):941-7. doi: 10.4065/mcp.2011.0373.

11.

A 26-year-old woman with recurrent loss of consciousness.

Benson MR, Kotagal V, Oral H.

J Gen Intern Med. 2011 Dec;26(12):1507-12. doi: 10.1007/s11606-011-1784-8. Epub 2011 Jul 8.

12.

Genotype-specific QT correction for heart rate and the risk of life-threatening cardiac events in adolescents with congenital long-QT syndrome.

Barsheshet A, Peterson DR, Moss AJ, Schwartz PJ, Kaufman ES, McNitt S, Polonsky S, Buber J, Zareba W, Robinson JL, Ackerman MJ, Benhorin J, Towbin JA, Vincent GM, Zhang L, Goldenberg I.

Heart Rhythm. 2011 Aug;8(8):1207-13. doi: 10.1016/j.hrthm.2011.03.009. Epub 2011 Mar 10.

13.

Genetic testing for potentially lethal, highly treatable inherited cardiomyopathies/channelopathies in clinical practice.

Tester DJ, Ackerman MJ.

Circulation. 2011 Mar 8;123(9):1021-37. doi: 10.1161/CIRCULATIONAHA.109.914838. Review. No abstract available.

14.

Recurrent and Founder Mutations in the Netherlands: the Long-QT Syndrome.

Hofman N, Jongbloed R, Postema PG, Nannenberg E, Alders M, Wilde AA.

Neth Heart J. 2011 Jan;19(1):10-16. Epub 2010 Dec 17.

15.

Trigger-specific risk factors and response to therapy in long QT syndrome type 2.

Kim JA, Lopes CM, Moss AJ, McNitt S, Barsheshet A, Robinson JL, Zareba W, Ackerman MJ, Kaufman ES, Towbin JA, Vincent M, Goldenberg I.

Heart Rhythm. 2010 Dec;7(12):1797-805. doi: 10.1016/j.hrthm.2010.09.011. Epub 2010 Sep 17.

16.

Risk stratification in young patients with channelopathies.

Sreeram N, Trieschmann U, Khalil M, Emmel M.

Indian Pacing Electrophysiol J. 2010 Jun 5;10(6):257-73.

17.

Epinephrine-Induced Polymorphic Ventricular Tachycardia in a Patient With Congenital Long QT Syndrome.

Kim JH, Park SH, Kim KH, Choi WS, Kang JK, Kim NY, Cho Y.

Korean Circ J. 2009 Sep;39(9):386-8. doi: 10.4070/kcj.2009.39.9.386. Epub 2009 Sep 30.

18.

Importance of Knowing the Genotype and the Specific Mutation When Managing Patients with Long QT Syndrome.

Moss AJ, Goldenberg I.

Circ Arrhythm Electrophysiol. 2008 Aug;1(3):213-26; discussion 226. doi: 10.1161/CIRCEP.108.796599. Review. No abstract available.

19.

Pharmacological approach to the treatment of long and short QT syndromes.

Patel C, Antzelevitch C.

Pharmacol Ther. 2008 Apr;118(1):138-51. doi: 10.1016/j.pharmthera.2008.02.001. Review.

20.
Items per page

Supplemental Content

Write to the Help Desk